Literature DB >> 12034143

Postnatal maternal deprivation aggravates experimental autoimmune encephalomyelitis in adult Lewis rats: reversal by chronic imipramine treatment.

Michael Stephan1, Rainer H Straub, Torbjørn Breivik, Reinhard Pabst, Stephan von Hörsten.   

Abstract

Stressful experiences can modulate multiple sclerosis, but stress protection is currently not considered a treatment option. Here, we show that maternal deprivation, an adverse stress experience in infancy, increases emotionality in behavioral tests of adult female Lewis rats and concomitantly causes a more severe course of experimental autoimmune encephalomyelitis. Treatment of these effects in adulthood by chronic antidepressants (imipramine) reversed the behavioral symptoms and attenuated the course of the encephalomyelitis in deprived rats. Increased IL-4 plasma levels accompanied the protective-like effects of antidepressants. In contrast, attempts to prevent these effects in infancy by tactile stimulation aggravated the encephalomyelitis, possibly by decreasing corticosterone and increasing IFN-gamma levels during the disease. This indicates that antidepressants exert protective effects in an animal model of multiple sclerosis, and suggests that drugs modifying stress responsiveness may have a potential role as adjuvant treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034143     DOI: 10.1016/s0736-5748(02)00007-2

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  8 in total

1.  Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model.

Authors:  Roma Kalra; Shashi P Singh; Juan C Pena-Philippides; Raymond J Langley; Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 2.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice.

Authors:  M W Meagher; A N Sieve; R R Johnson; D Satterlee; M Belyavskyi; W Mi; T W Prentice; T H Welsh; C J R Welsh
Journal:  Behav Genet       Date:  2010-02-05       Impact factor: 2.805

4.  Maternal Deprivation of Lewis Rat Pups Increases the Severity of Experi-mental Periodontitis in Adulthood.

Authors:  Torbjørn Breivik; Yngvar Gundersen; Robert Murison; Jonathan D Turner; Claude P Muller; Per Gjermo; Kristian Opstad
Journal:  Open Dent J       Date:  2015-01-30

5.  Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling.

Authors:  Yee Ming Khaw; Danish Majid; Sungjong Oh; Eunjoo Kang; Makoto Inoue
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

Review 6.  Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models.

Authors:  E L Harrison; B T Baune
Journal:  Transl Psychiatry       Date:  2014-05-13       Impact factor: 6.222

Review 7.  Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models.

Authors:  Eleni Stamoula; Spyridon Siafis; Ioannis Dardalas; Alexandra Ainatzoglou; Alkis Matsas; Theodoros Athanasiadis; Chrysanthi Sardeli; Konstantinos Stamoulas; Georgios Papazisis
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

8.  Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activation.

Authors:  Natalia Duque-Wilckens; Robert Teis; Erika Sarno; Frauke Stoelting; Sonia Khalid; Zakaria Dairi; Alex Douma; Nidia Maradiaga; Stina Hench; Christine D Dharshika; Kyan M Thelen; Brian Gulbransen; A J Robison; Adam J Moeser
Journal:  Brain Behav Immun       Date:  2022-03-24       Impact factor: 19.227

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.